Actavis Totowa Recalls Digitek (digoxin) tablets

Susan Devine
Susan Devine
Contributor
Posted by Susan DevineMay 14, 2008 6:05 PM

On April 25, 2008 Actavis Totowa LLC, a manufacturer of generic medication, issued a Class I nationwide recall of Digitek, a generic form of digoxin tablets.  The company's press release can be found here.  The products are distributed by Mylan Pharmaceuticals, Inc. under a "Bertek" label and by UDL Laboratories under a "UDL" label.  The FDA is aware of the recall.

Digitek is used to treat heart failure and abnormal heart rhythms and the voluntary recall was issued because at least some of the tablets that were released were oversized and could contain at least twice the level of active ingredients than is appropriate. 

It has been reported that some individuals have been seriously injured as a result of taking the wrong sized tablets. Consumer attorneys are working on lawsuits in the hopes that those who have been injured will be compensated and to help ensure these kinds of mistakes do not happen again.   If you have been injured as a result of taking this medication, or even if you are not sure, contact your doctor immediately.  And if you have questions about your legal rights, contact a local attorney.

 

0 Comments

Have an opinion about this post? Please consider leaving a comment or subscribing to the feed to have future articles delivered to your feed reader.

Comments for this article are closed.

Subscribe to InjuryBoard San Luis Obispo

InjuryBoard San Luis Obispo RSS Feeds

Keep up with the latest updates using your favorite RSS reader

Legal Assistance Center

More Info
Better Business Bureau Accredited Business Confidential

Your question will be referred to an attorney near you. If your question is of a legal nature, then by submitting this form you agree you are not forming a formal attorney / client relationship. Read our full privacy policy.

Looking for an InjuryBoard attorney closer to home? Click here.

Subscribe to Blog Updates

Enter your email address if you would like to receive email notifications when comments are made on this post.

Email address